1 H, J5b ,5a 11.6, J5b ,4 5.2 Hz, H-5bꢀ), 4.11 (d, 1 H, J1,2 9.1 Hz,
The resulting plasmids were designated pR2CFXcd-E235G(His)6
and pR2CFXcd-E235S(His)6. The nucleophile mutants of CFXcd
were purified by affinity chromatography using Ni-NTA agarose
(Qiagen).
ꢀ
ꢀ
ꢀ ꢀ
H-1), 4.24 (d, 1 H, J1 ,2 7.5 Hz, H-1ꢀ), 7.13–7.26 (m, 5H, Bn);
13C NMR (CD3OD, 100 MHz, ppm): d 34.78, 67.24, 68.10, 71.21,
74.23, 74.44, 77.34, 77.75, 78.09, 86.27, 104.06, 128.19, 129.61
(2C), 130.32 (2C), 139.57; HRMS (ESI, M + Na+): m/z calc. for
C17H24O8S + Na+ = 411.1089; found 411.1090.
ꢀ
ꢀ
Enzymatic synthesis and isolation of xylo-oligosaccharides
To a mixture of aX2F (15 mg, 53 lmol) and PNPX2 (20 mg, 50
lmol) in NaH2PO4/Na2HPO4 buffer (5 mL of 0.1 M, pH 7.0) was
added CFXcd-E235G (1.4 mg) and the mixture then incubated
at room temperature. Upon consumption of the donor sugar (ca.
10 h), as determined by TLC, an additional 15 mg of aX2F was
added to the reaction to give a total added 2 : 1 ratio of aX2F
: PNPX2). Benzylthio xylo-oligosaccharides were synthesized in
a similar manner by incubating aX2F (15 mg, 53 lmol) and
BTX2 (19 mg, 49 lmol) in NaH2PO4/Na2HPO4 buffer (3 mL of
0.1 M, pH 7.0) in the presence of CFXcd-E235G (1.4 mg). Upon
consumption of donor sugar an additional 15 mg of aX2F was
added at 3 and 10 h, respectively, to give a total added 3 : 1 ratio
of aX2F : BTX2. After 24 h incubation, the reaction mixture was
loaded onto a C18 SEP PAK cartridge (Waters) to remove non-aryl
sugars, enzyme, and salts. The cartridge was washed with 6 mL
of water and then the aryl xylo-oligosaccharides were eluted with
6 mL of 50% (v/v) methanol–water. The solvents were evaporated
under reduced pressure and the residues loaded onto a preparative
Tosoh Amide-80 (2.15 × 30 cm) column. The products were eluted
at 6 mL min−1 with an acetonitrile–water (70 : 30 to 20 : 80 for
50 min) gradient.
Construction of pR2CFXcd(His)6 and purification of CFXcd
The gene fragment encoding the catalytic domain of CFX was
amplified by PCR using 1 lM of CFX-TOP-Nco-fw primer
(5ꢀ-GCGAGTGACCATGGCCACGAAACTCCACGCGAC-3ꢀ)
and CFXcd-END-Not-rev primer (5ꢀ-GTCACGTGCGCGG-
CCGCATGACCCGCTGAC-3ꢀ), 0.2 mM each of the four
17
dNTPs, 5% DMSO, 25 ng of pR2CFX(His)6 as template
DNA, and 2.5 U of Pwo polymerase (Roche) in 50 lL 1 × Pwo
polymerase buffer. Twenty-five PCR cycles (30 s at 96 ◦C, 30 s
◦
◦
at 65 C and 45 s at 72 C) were performed in a thermal cycler
(Perkin Elmer, GeneAmp PCR System 2400). The resulting
PCR product was digested with NcoI and XhoI and then sub-
cloned into pR2TK.17 The resulting plasmid was designated
as pR2CFXcd(His)6. CFXcd was purified from E. coli TOP10
cells harboring pR2CFXcd(His)6 by affinity chromatography
using Ni-NTA agarose (Qiagen), as previously described.17
Desalting and the concentration of purified enzyme solutions
were carried out using an Amicon Ultra-4 filter unit (10 000 Da
cut-off, Millipore). The buffer used in enzyme solutions was
exchanged for 100 mM NaH2PO4/Na2HPO4 buffer, pH 7.0.
Protein concentration was determined using the Micro BCATM
protein assay reagent kit (Pierce) using BSA as a standard.
Acknowledgements
We thank the Natural Sciences and Engineering Council of
Canada, the Protein Engineering Network of Centres of Ex-
cellence of Canada, the Michael Smith Foundation for Health
Research (for Y. W. K.), and Commonwealth Scholarship (to T. K.)
for financial support. We also thank Dr H. Chen for the synthesis
of PNPX2 and Ms V. Y. L. Yip for help with NMR analysis.
Kinetic analysis of aryl glycoside hydrolysis
Initial rates of hydrolysis of PNPX, PNPG, PNPX2, and PNPC
catalyzed by CFXcd in 50 mM NaH2PO4/Na2HPO4, pH 6.5,
0.1% BSA were determined at 37 ◦C by monitoring the reactions
spectrophotometrically at 400 nm as described before.17 The values
of Km and kcat were determined by fitting the initial velocity curves
to the Michaelis–Menten equation using non-linear regression
with the program GraFit.
References
1 B. C. Saha, J. Ind. Microbiol. Biotechnol., 2003, 30, 279–291.
2 S. Subramaniyan and P. Prema, Crit. Rev. Biotechnol., 2002, 22, 33–64.
3 M. J. Vazquez, J. L. Alonso, H. Dominguez and J. C. Parajo, Trends
Food Sci. Technol., 2000, 11, 387–393; K. Koga and S. Fujikawa, in
Oligosaccarides. Production, Properties and Applications, T. Nakakuki,
ed., Gordon & Breach, Switzerland, 1993, vol. 3, pp. 130–143.
4 H. J. Sun, S. Yoshida, N. H. Park and I. Kusakabe, Carbohydr. Res.,
2002, 337, 657–661.
5 K. Takeo, Y. Ohguchi, R. Hasegawa and S. Kitamura, Carbohydr. Res.,
1995, 278, 301–313.
6 E. V. Eneyskaya, H. Brumer, III, L. V. Backinowsky, D. R. Ivanen,
A. A. Kulminskaya, K. A. Shabalin and K. N. Neustroev, Carbohydr.
Res., 2003, 338, 313–325.
7 E. V. Eneyskaya, D. R. Ivanen, K. A. Shabalin, A. A. Kulminskaya,
L. V. Backinowsky, H. Brumer and K. N. Neustroev, Org. Biomol.
Chem., 2005, 3, 146–151.
8 H. Kuroyama and Y. Tsumuraya, Planta, 2001, 213, 231–240.
9 S. J. Williams and S. G. Withers, Aust. J. Chem., 2002, 55, 3–12; G.
Perugino, A. Trincone, M. Rossi and M. Moracci, Trends Biotechnol.,
2004, 22, 31–37.
Site-directed mutagenesis to construct CFX-E235G and
CFX-E235S
Mutations of the catalytic nucleophile of CFXcd were
introduced using
a mega primer PCR method. Plasmid
pR2CFXcd(His)6 was used as template for the mutagenesis.
The 3ꢀ-end of the gene fragment for CFX-E235G was ampli-
fied with the T7 terminator primer and CFX-E235G-fw (5ꢀ-
GACGTGCAGATCACCGGCCTCGACATCGAG-3ꢀ, the mu-
tated codon is underlined), while the primer CFX-E235S-fw
(5ꢀ-GACGTGCAGATCACCAGCCTCGACATC GAG-3ꢀ) was
used for CFX-E235S. The PCR products were purified using a
QIAquick Gel Extraction Kit (Qiagen) and then used as mega
primers to obtain the full-length genes with the CFX-TOP-Nco-
fw primer. The full-length PCR products were digested with NcoI
and XhoI, the products separated by agarose gel electrophoresis,
and the desired fragments were extracted from agarose gel using a
QIAquick Gel Extraction Kit and ligated into the pR2TK vector
previously digested with the corresponding restriction enzymes.
10 G. Perugino, B. Cobucci-Ponzano, M. Rossi and M. Moracci, Adv.
Synth. Catal., 2005, 347, 941–950.
11 J. Drone, H. Feng, C. Tellier, L. Hoffmann, V. Tran, C. Rabiller and M.
Dion, Eur. J. Org. Chem., 2005, 2005, 1977–1983.
12 Y. Honda and M. Kitaoka, J. Biol. Chem., 2006, 281, 1426–1431.
This journal is
The Royal Society of Chemistry 2006
Org. Biomol. Chem., 2006, 4, 2025–2032 | 2031
©